These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14671028)

  • 1. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
    Vogt L; Laverman GD; Dullaart RP; Navis G
    Nephrol Dial Transplant; 2004 Jan; 19(1):5-8. PubMed ID: 14671028
    [No Abstract]   [Full Text] [Related]  

  • 2. PCSK9 inhibitors- A new age in lipid management?
    Grant PJ
    Diab Vasc Dis Res; 2017 May; 14(3):171. PubMed ID: 28467196
    [No Abstract]   [Full Text] [Related]  

  • 3. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis.
    Fried L; Hutchison A; Stegmayr B; Prichard S; Bargman JM
    Perit Dial Int; 1999; 19(1):7-16. PubMed ID: 10201335
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target.
    Cesaro A; Riccio C; Calabrò P
    Monaldi Arch Chest Dis; 2021 May; 91(2):. PubMed ID: 33942600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severely frail elderly patients do not need lipid-lowering drugs.
    Mallery LH; Moorhouse P; McLean Veysey P; Allen M; Fleming I
    Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T; Ishigami M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of antiproteinuric treatment on the lipid profile in nondiabetic renal disease.
    Navis G; Buter H; de Jong PE; Dullaart RP; de Zeeuw D
    Contrib Nephrol; 1997; 120():88-96. PubMed ID: 9257051
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 10. One great leap for lipid lowering drugs.
    Cardiovasc J S Afr; 2002; 13(5):265-6. PubMed ID: 12557874
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statins].
    Kobayashi J
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():618-21. PubMed ID: 17458292
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients.
    Pascual Fuster V
    Rev Esp Sanid Penit; 2016 Dec; 18(3):95-108. PubMed ID: 27831597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications for the pharmacologic treatment of hyperlipidemias].
    Cía Gómez P
    Rev Clin Esp; 2000 Nov; 200(11):622-5. PubMed ID: 11196593
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid-lowering drug therapies: the evidence.
    Packard C
    Proc Nutr Soc; 2000 Aug; 59(3):423-4. PubMed ID: 10997662
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipids: diagnosis and therapy in type 2 diabetes].
    Wascher TC; Paulweber B; Toplak H; Saely C; Drexel H
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():28-30. PubMed ID: 23250461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the editor: drugs, genes, and lipoproteins.
    Brown WV
    J Clin Lipidol; 2014; 8(6):529-530. PubMed ID: 25499933
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperlipidaemia and cardiovascular disease: statin update.
    Roberts AW; Salim M
    Curr Opin Lipidol; 2007 Jun; 18(3):381-3. PubMed ID: 17495613
    [No Abstract]   [Full Text] [Related]  

  • 19. Justifying lipid-lowering therapy in persons >/=65 years of age.
    LaRosa JC
    Am J Cardiol; 2002 Dec; 90(12):1330-2. PubMed ID: 12480043
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid-lowering agents in proteinuric diseases.
    Appel GB; Appel AS
    Am J Nephrol; 1990; 10 Suppl 1():110-5. PubMed ID: 2256470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.